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INTRODUCTION
  We are living in a society of increasing competition and 
as a result, the gap between the rich and poor has been 
widened. In this society, the ideal model of the advanced 
welfare state would be the one that could help people in 
their crises before they fall into a class of extreme poverty. 
Cancer, for example, is difficult to deal with by any in-
dividual due to its expensive and long-term management, 
and this can be a huge risk factor in family economy which 
can lead to a crisis. In this aspect, the national health in-
surance (NHI) could be considered as a great policy that 
pays for the medical fees, which helps and protects patients 
and families from high medical bills.
  Korean NHI has become an important means of maintain-
ing national health care, where the government operates 
the system with its own budget in addition to health in-
surance fees collected from people. Although our health 
insurance system started mostly based on Japanese national 
health insurance system, it is regarded as a highly beneficial 
policy that covers all people, providing high quality medical 
services with less cost. 
CONFLICTS BETWEEN HEALTH INSURANCE, HOSPITAL, 
AND PATIENTS
  Some people prepare for the risk of cancer through private 
commercial health insurance, however, most of the people 
generally have to be dependent on the NHI for cancer 
treatment. But, this support alone does not resolve the eco-
nomic problems faced by patients and families. There are 
still many effective cancer treatments, which have not been 
reimbursed by the NHI. 
  As sometimes reported by media, many problems posed 
on patient's family come from the financial problems caused 
by these non-reimbursement treatments. In these situations, 
conflicts between the NHI, hospital, and patient's family 
are inevitable. Hospital claims that a treatment which has 
been proven to be effective in developed countries should 
be applied for better results of treatment, even if such treat-
ment cannot be reimbursed. However, the NHI claims that 
hospital is performing unnecessary treatment for profit of 
the hospital, and considers it as an over-practice. On the 
other hand, patient and family claim that they are un-
reasonably burdened when the effective medical service 
is not reimbursed. Sometimes the patients file comments 
and complaints about the insurance system even once they 
decided to receive non-reimbursement treatments.
NEED FOR A COMPREHENSIVE AND UNIFORMED 
TREATMENT PROTOCOL 
  The most important matter for the patient is to recover 
from the disease. It would be acceptable, if the patient 
could be cured only by the treatments approved by the 
NHI. However, the patient would be devastated if he or 
she chose a reimbursement treatment instead of non-re-
imbursement treatment and the result was poor. Thus, pa-
tient's family tends to choose the treatment option that 
can be more beneficial to the patient regardless of the cost. Korean J Hematol 2010;45:217-8.
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Most people will trust and follow hospitals and doctors, 
if they recommend the best treatment options to patients 
without considering the profit. However, since that may 
not be always the case in reality, patients and families have 
difficulties in selecting the method of treatment and they 
may build distrust towards hospitals and doctors. 
  In bottom line, the patient and family want the Health 
Insurance Review and Assessment Service to provide them 
with a uniformed treatment protocol that could easily help 
them in choosing the best possible treatment options at 
times of tough decisions. Such a protocol exists today, but 
its standard of level seems so low that there is a concern 
for the low quality of medical service. It is now time that 
an upgraded uniformed treatment protocol apt with our 
standard of living is needed. Since the clinical conditions 
of patients are so diverse, a uniformed treatment protocol 
could not be applied in some cases. Such exceptional cases 
can be left to doctors’ discretion. For all other general cases, 
national insurance should do its role allowing patients to 
receive the best medical service according to the upgraded 
uniformed treatment protocol. 
  If a new treatment option that is not included in the 
protocol is effective, patients and families would want to 
be treated by the new treatment regardless of the cost. 
Thus, there should be a legal policy to guarantee that the 
new treatment would not become illegal. Doctor’s enthusi-
astic mind to cure the disease should be encouraged and 
medical approach towards the new treatment should not 
be withered.
NEED FOR EXPANSION OF SUPPORT BY NATIONAL 
HEALTH INSURANCE 
  The incidence of pediatric cancer is about 13 per 100,000 
of population, and 1,200 children with age of under 15 
years become new pediatric cancer patients every year in 
Korea. Leukemia is the most frequent disease that comprises 
40% of all pediatric cancers, and it requires about 2 to 
3 years of long-term treatment. Not only the direct cost 
for the treatment is a burden, but extra costs (transportation 
cost, food, sanitation related costs, and etc.) that are spent 
in addition to the treatment is also very high, and in fact, 
many patients' families appeal for supports in those costs. 
According to the analyses of Korean National Cancer Regis-
try data and the NHI data by National Cancer Management 
Project Team from National Cancer Center, a total of 478,446 
cancer patients visited hospitals in 2005 and spent 2.3 trillion 
won as a medical cost, 900 billion won as a private nursing, 
transportation, and alternative treatment. 
  Korea Childhood Leukemia Foundation (KCLF) supports 
direct treatment cost as well as extra costs and living 
expenses. In 2009, we supported a total of 1,523,922,602 
won, and extra cost support was 173,258,820 won compris-
ing 11.4%. If the burden of direct treatment cost could 
be reduced by the expansion of support from the NHI, 
private fund like KCLF could then contribute more to sup-
port extra costs as well as costs for cancer treatment compli-
cation and for mental support projects that could help en-
hance the quality of lives of patients and families. 
CONCLUSION
  Every patient wants effective treatment and complete 
recovery from the disease. Organized system between the 
NHI, hospitals, and medical staffs is in need. The preparation 
of extensive and comprehensive treatment protocol and the 
expansion of health insurance support would help reduce 
the economic burden caused by diseases including cancer. 
Every person's life is sacred, and everyone has a right to 
live a healthy life. More systematic and rational policy is 
needed to maintain healthy lives, and this enhanced system 
will not only resolve the crises of patients, but will be 
a vital force that could keep our families and our society 
to stay healthy. 